| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |